Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18939-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- MIDN antibody
- Antibody type
- Polyclonal
- Description
- MIDN antibody (Cat. #18939-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Matrix stiffness induces midnolin-dependent lamin B1 degradation to control myoblast differentiation.
Targeted degradation of c-Myc through the midnolin-proteasome pathway.
Midnolin Correlates With Anti-Tumour Immunity and Promotes Liver Cancer Progression Through β-Catenin.
Midnolin inhibits coronavirus proliferation by degrading viral proteins.
Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker.
Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.
The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.
CREB Promotes Beta Cell Gene Expression by Targeting Its Coactivators to Tissue-Specific Enhancers.
Guo L, Zhao Y, Zhang Z, Sun C, Xie Y, Dai Q, Yan Y, Zhou Y, Zhang Y, Li Q, Qiu J, Peng Q
EMBO reports 2026 May;27(9):2297-2318
EMBO reports 2026 May;27(9):2297-2318
Targeted degradation of c-Myc through the midnolin-proteasome pathway.
Zhao J, Wu H, Yu H, Li C, Mao Y, Yuan H, Li S
Proceedings of the National Academy of Sciences of the United States of America 2026 Apr 14;123(15):e2520128123
Proceedings of the National Academy of Sciences of the United States of America 2026 Apr 14;123(15):e2520128123
Midnolin Correlates With Anti-Tumour Immunity and Promotes Liver Cancer Progression Through β-Catenin.
Huang S, Zhang J, He T, Zhou J, Liu Z
Journal of cellular and molecular medicine 2025 Mar;29(6):e70472
Journal of cellular and molecular medicine 2025 Mar;29(6):e70472
Midnolin inhibits coronavirus proliferation by degrading viral proteins.
Wang Y, Tong W, Qin W, Yang X, Yu H, Zheng H, Zhang W, Tong G, Wang C, Kong N, Shan T
Journal of virology 2025 Jun 17;99(6):e0036625
Journal of virology 2025 Jun 17;99(6):e0036625
Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker.
Zhang XG, Li WT, Jin X, Fu C, Jiang W, Bai J, Shi ZZ
Biomedicines 2025 Jan 23;13(2)
Biomedicines 2025 Jan 23;13(2)
Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.
Wang W, Kong P, Feng K, Liu C, Gong X, Sun T, Duan X, Sang Y, Jiang Y, Li X, Zhang L, Tao Z, Liu W
Cancer science 2023 Nov;114(11):4252-4269
Cancer science 2023 Nov;114(11):4252-4269
The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.
Gu X, Nardone C, Kamitaki N, Mao A, Elledge SJ, Greenberg ME
Science (New York, N.Y.) 2023 Aug 25;381(6660):eadh5021
Science (New York, N.Y.) 2023 Aug 25;381(6660):eadh5021
CREB Promotes Beta Cell Gene Expression by Targeting Its Coactivators to Tissue-Specific Enhancers.
Van de Velde S, Wiater E, Tran M, Hwang Y, Cole PA, Montminy M
Molecular and cellular biology 2019 Sep 1;39(17)
Molecular and cellular biology 2019 Sep 1;39(17)
No comments: Submit comment
No validations: Submit validation data